Cadila Receives U.S. FDA Warning for Manufacturing Violations

The Ahmedabad-based pharmaceutical company Zydus Cadila said it had received a warning letter from the FDA over violations of current good manufacturing practices or cGMP regulations for finished pharmaceuticals at its Moraiya facility near Ahmedabad, reports said.
RTTNews